NO20006155D0 - Texaphyrinkonjugater og anvendelse derav - Google Patents
Texaphyrinkonjugater og anvendelse deravInfo
- Publication number
- NO20006155D0 NO20006155D0 NO20006155A NO20006155A NO20006155D0 NO 20006155 D0 NO20006155 D0 NO 20006155D0 NO 20006155 A NO20006155 A NO 20006155A NO 20006155 A NO20006155 A NO 20006155A NO 20006155 D0 NO20006155 D0 NO 20006155D0
- Authority
- NO
- Norway
- Prior art keywords
- platinum
- texaphyrin
- conjugates
- texaphyrin conjugates
- neovascular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
- A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
- A61K47/546—Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8821498P | 1998-06-05 | 1998-06-05 | |
| PCT/US1999/012614 WO1999062551A1 (en) | 1998-06-05 | 1999-06-04 | Texaphyrin conjugates and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006155D0 true NO20006155D0 (no) | 2000-12-04 |
| NO20006155L NO20006155L (no) | 2001-02-02 |
Family
ID=22210058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006155A NO20006155L (no) | 1998-06-05 | 2000-12-04 | Texafyrinkonjugater og anvendelse derav |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6207660B1 (no) |
| EP (1) | EP1082138B1 (no) |
| JP (1) | JP2002516878A (no) |
| KR (1) | KR20010052616A (no) |
| AT (1) | ATE274357T1 (no) |
| AU (1) | AU4232199A (no) |
| CA (1) | CA2334809A1 (no) |
| DE (1) | DE69919695T2 (no) |
| NO (1) | NO20006155L (no) |
| WO (1) | WO1999062551A1 (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7611533B2 (en) * | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
| US20060052757A1 (en) * | 1996-06-04 | 2006-03-09 | Vance Products Incorporated, D/B/A Cook Urological Incorporated | Implantable medical device with analgesic or anesthetic |
| US20060030826A1 (en) * | 1996-06-04 | 2006-02-09 | Vance Products Incorporated,d/b/a Cook Urological Incorporated | Implantable medical device with anti-neoplastic drug |
| US20060025726A1 (en) * | 1996-06-04 | 2006-02-02 | Vance Products Incorporated, D/B/A Cook Urological Incorporated | Implantable medical device with pharmacologically active layer |
| US20020155999A1 (en) * | 1998-04-30 | 2002-10-24 | Han In Suk | Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer |
| GB9904386D0 (en) * | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| US7312244B2 (en) * | 1999-04-30 | 2007-12-25 | Cellgate, Inc. | Polyamine analog-amino acid conjugates useful as anticancer agents |
| DE60029944T2 (de) * | 1999-04-30 | 2007-04-05 | Cellgate, Inc., Redwood City | Polyamine und ihre therapeutische verwendung |
| HK1050315A1 (zh) * | 1999-10-29 | 2003-06-20 | Pharmacyclics, Inc. | 用於治疗粉瘤，肿瘤以及其他新生组织的共扼化合物 |
| CA2424345A1 (en) * | 2000-10-16 | 2002-04-25 | Neopharm, Inc. | Liposomal formulation of mitoxantrone |
| US6485704B1 (en) * | 2001-05-04 | 2002-11-26 | Mallinckrodt Inc. | Azo compound for type I pototherapy |
| US20030082101A1 (en) * | 2001-06-11 | 2003-05-01 | Cavalier Discovery | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species |
| AU2002351382A1 (en) * | 2001-12-13 | 2003-06-23 | Pharmacyclics, Inc. | Combination cancer therapy |
| US20050261171A1 (en) * | 2001-12-13 | 2005-11-24 | Pharmacyclics, Inc. | Combination cancer therapy |
| EP1515973A1 (en) * | 2002-06-26 | 2005-03-23 | Cellgate Inc. | Porphyrin-polyamine conjugates for cancer therapy |
| US20040192665A1 (en) * | 2002-08-02 | 2004-09-30 | Slil Biomedical Corporation | Conjugates of porphyrin compounds with chemotherapeutic agents |
| US20090299263A1 (en) * | 2002-08-28 | 2009-12-03 | Nomir Medical Technologies, Inc. | Near-Infrared electromagnetic modification of cellular steady-state membrane potentials |
| CN101791409A (zh) * | 2003-04-22 | 2010-08-04 | 研究及应用科学协会股份有限公司 | 肽载体 |
| CN1863771A (zh) | 2003-10-07 | 2006-11-15 | 悉尼西部大学 | 序列选择性吡咯和咪唑聚酰胺金属复合物 |
| US8710020B2 (en) * | 2004-04-02 | 2014-04-29 | The University Of British Columbia | Clusterin antisense therapy for treatment of cancer |
| WO2005112759A1 (en) * | 2004-05-20 | 2005-12-01 | Pharmacyclics, Inc. | A method of enhancing visualization of atherosclerotic plaque |
| DE102005055358A1 (de) * | 2005-11-21 | 2007-05-24 | Robert Bosch Gmbh | Vorrichtung und Verfahren zum Aufrichten und Übergeben von Faltschachteln |
| US8133474B2 (en) * | 2006-09-15 | 2012-03-13 | Massachusetts Institute Of Technology | Sensors for fluorescence and magnetic resonance imaging |
| KR100800391B1 (ko) | 2007-04-06 | 2008-02-01 | 김익중 | 균열방지용 황토미장 시공방법 |
| US20090062724A1 (en) * | 2007-08-31 | 2009-03-05 | Rixen Chen | System and apparatus for sonodynamic therapy |
| KR102412203B1 (ko) * | 2014-06-11 | 2022-06-23 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 백금 내성을 극복하는데 이용하기 위한 텍사피린-pt(iv) 접합체 및 조성물 |
| KR20230067608A (ko) | 2020-08-14 | 2023-05-16 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 망간 화학 요법, 광음향 이미징, 및 광열 요법을 위한 텍사피린 유도체 |
| CN114539552B (zh) * | 2022-03-31 | 2023-05-02 | 西安交通大学 | 一种铂基卟啉金属笼及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5041578A (en) * | 1988-11-22 | 1991-08-20 | Board Of Regents, The University Of Texas System | Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents |
| US5457183A (en) * | 1989-03-06 | 1995-10-10 | Board Of Regents, The University Of Texas System | Hydroxylated texaphyrins |
| US5457195A (en) * | 1989-12-21 | 1995-10-10 | Board Of Regents, The University Of Texas System | Sapphyrin derivatives and conjugates |
| JP3131219B2 (ja) * | 1990-01-19 | 2001-01-31 | ニユコメド・イメージング・アクシエセルカペト | キレート化合物 |
| CA2082934C (en) * | 1990-05-15 | 2003-08-05 | Walter B. Dandliker | Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents |
| US5595726A (en) * | 1992-01-21 | 1997-01-21 | Pharmacyclics, Inc. | Chromophore probe for detection of nucleic acid |
| US5565552A (en) * | 1992-01-21 | 1996-10-15 | Pharmacyclics, Inc. | Method of expanded porphyrin-oligonucleotide conjugate synthesis |
| US5888997A (en) * | 1994-04-14 | 1999-03-30 | Pharmacyclics, Inc. | Radiation sensitization using texaphyrins |
| WO1997019938A1 (es) * | 1995-11-29 | 1997-06-05 | Consejo Superior Investigaciones Cientificas | Derivados fluorescentes de paclitaxel y docetaxel con actividad antineoplasica, metodo para obtenerlos y sus aplicaciones |
| ES2151277T3 (es) * | 1996-05-22 | 2000-12-16 | Protarga Inc | Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere. |
| GB9710049D0 (en) * | 1997-05-19 | 1997-07-09 | Nycomed Imaging As | Method |
| DE19824653A1 (de) * | 1998-02-25 | 1999-08-26 | Schering Ag | Nekrose-affine Verbindungen und ihre Verwendung zur Herstellung von Präparaten zur Pharmakotherapie |
-
1999
- 1999-06-04 WO PCT/US1999/012614 patent/WO1999062551A1/en not_active Ceased
- 1999-06-04 CA CA002334809A patent/CA2334809A1/en not_active Abandoned
- 1999-06-04 US US09/325,890 patent/US6207660B1/en not_active Expired - Fee Related
- 1999-06-04 AU AU42321/99A patent/AU4232199A/en not_active Abandoned
- 1999-06-04 JP JP2000551806A patent/JP2002516878A/ja active Pending
- 1999-06-04 DE DE69919695T patent/DE69919695T2/de not_active Expired - Fee Related
- 1999-06-04 EP EP99926172A patent/EP1082138B1/en not_active Expired - Lifetime
- 1999-06-04 KR KR1020007013821A patent/KR20010052616A/ko not_active Withdrawn
- 1999-06-04 AT AT99926172T patent/ATE274357T1/de not_active IP Right Cessation
-
2000
- 2000-12-04 NO NO20006155A patent/NO20006155L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20006155L (no) | 2001-02-02 |
| DE69919695T2 (de) | 2005-09-15 |
| ATE274357T1 (de) | 2004-09-15 |
| US6207660B1 (en) | 2001-03-27 |
| WO1999062551A1 (en) | 1999-12-09 |
| CA2334809A1 (en) | 1999-12-09 |
| JP2002516878A (ja) | 2002-06-11 |
| DE69919695D1 (de) | 2004-09-30 |
| KR20010052616A (ko) | 2001-06-25 |
| AU4232199A (en) | 1999-12-20 |
| EP1082138B1 (en) | 2004-08-25 |
| EP1082138A1 (en) | 2001-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20006155L (no) | Texafyrinkonjugater og anvendelse derav | |
| DE69834923D1 (en) | Hochgradig lipophile camptothecin-derivate | |
| DE59611341D1 (de) | Verwendung von saccharid-konjugaten | |
| DE60003583D1 (de) | Arylaminderivate und ihre verwendung als antitelomerasemittel | |
| DK1200590T3 (da) | C-type lectin-transmembran-antigen, der udtrykkes ved human prostatacancer, og anvendelser deraf | |
| MXPA01010393A (es) | Tratamiento de neoplasmas con virus. | |
| TR200002243T2 (tr) | Arsenik trioksitin hazırlanması için işlem ve bunların kanser tedavisi için kullanımı. | |
| DE69828436D1 (de) | Radioaktive embolisierende zusammensetzungen | |
| PT754176E (pt) | Novos carbamatos e ureias como modificadores da resistencia a multiplas drogas | |
| IS4073A (is) | Nýtt fjölvirknislyf gegn aukningu mótstöðu | |
| DE68912334D1 (de) | Immunokonjugate für krebs-diagnose und -therapie. | |
| NO20000752L (no) | Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser | |
| IS6375A (is) | Lyfjagjöf til öftrunar á blöðruhálskrabbameini | |
| BR0010702A (pt) | Novas quinonas como terapias de doenças | |
| TR199800270T1 (xx) | Kanser hastal�klar�n�n ilerlemesini �nlemede flukonazol kullan�m�. | |
| DE60210074D1 (de) | Neue metalloporphyrine und ihre verwendung als radiosensibilisatoren für die strahlentherapie | |
| DE69913351D1 (de) | Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen | |
| IL97055A0 (en) | Pharmaceutical compositions for sensitizing tumor cells comprising quinazolinedione derivatives | |
| DK1124566T3 (da) | Ikke-fermenteret osmotisk laxativ til behandling og forebyggelse af colorectale cancere | |
| DK1276501T5 (da) | Fremgangsmåde til behandling af tumorer under anvendelse af fotodynamisk terapi | |
| CY1106363T1 (el) | Χρηση του ενepγοποιημενου παραγοντα πηξης vii για την αγωγη των επαγομενων απο θρομβολυτικη θepαπεια μειζονων αιμορραγιων | |
| NO995109D0 (no) | Formuleringer inneholdende 1,2,4-benzotriazinoksyder | |
| TR200102576T2 (tr) | Kanser tedavisinde radyoaktif sisplatin | |
| DK0858341T3 (da) | Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin | |
| DK1154798T3 (da) | Molekyler til behandling og diagnose af tumorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |